CryoCell International Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

CryoCell International Stock Summary

CryoCell International competes with National HealthCare, InnovAge Holding, Pennant, Encompass Health, and Airsculpt Technologies. Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida. Cryo-Cell Intl operates under Medical Care Facilities classification in the United States and is traded on AMEX Exchange. It employs 83 people.

CryoCell International Key Financial Ratios

CryoCell International Key Balance Sheet Accounts

CryoCell International Key Income Statement Accounts

CryoCell International Key Cash Accounts

CryoCell Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CryoCell International's current stock value. Our valuation model uses many indicators to compare CryoCell International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CryoCell International competition to find correlations between indicators driving CryoCell International's intrinsic value. More Info.CryoCell International is number one stock in return on equity category among its peers. It is rated below average in return on asset category among its peers reporting about  0.03  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CryoCell International is roughly  34.36 . At this time, CryoCell International's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CryoCell International by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

CryoCell International Systematic Risk

Today, most investors in CryoCell International Stock are looking for potential investment opportunities by analyzing not only static indicators but also various CryoCell International's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of CryoCell International growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of CryoCell International help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CryoCell International. We use our internally-developed statistical techniques to arrive at the intrinsic value of CryoCell International based on widely used predictive technical indicators. In general, we focus on analyzing CryoCell Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CryoCell International's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. If investors know CryoCell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CryoCell International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of CryoCell International is measured differently than its book value, which is the value of CryoCell that is recorded on the company's balance sheet. Investors also form their own opinion of CryoCell International's value that differs from its market value or its book value, called intrinsic value, which is CryoCell International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CryoCell International's market value can be influenced by many factors that don't directly affect CryoCell International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CryoCell International's value and its price as these two are different measures arrived at by different means. Investors typically determine if CryoCell International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CryoCell International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.